產(chǎn)品詳情
| 中文名稱:莫匹拉韋 | 英文名稱:Molnupiravir |
| CAS:1686124-74-2 | 純度規(guī)格: 99 |
| 產(chǎn)品類別: 中間體 |
2024-11-01
莫匹拉韋
Molnupiravir
1g m/RMB
99
中間體
Molnupiravir EIDD-2801是一種高效的核糖核苷類似物的口服生物可利用形式，可抑制多種RNA病毒的復(fù)制，包括SARS-CoV-2。
EIDD-2801 是核糖核苷類似物 EIDD-1931 的口服生物可利用的異丙酯前藥。EIDD-2801 顯示出廣泛的抗流感病毒 (influenza virus) 和冠狀病毒 (coronaviruses) 的活性，如 SARS-CoV-2，MERS-CoV，SARS-CoV。EIDD-2801 有用于 COVID-19 和季節(jié)性，流行性流感的潛力。
EIDD-2801可抑制多種RNA病毒的復(fù)制，包括SARS-CoV-2（COVID-19的致病因子），通過兩種不同冠狀病毒（SARS-CoV1和MERS）的動(dòng)物研究，證明EIDD-2801可以改善肺功能、減少體重減輕并減少肺中的病毒量。除了針對(duì)冠狀病毒的活性外，在實(shí)驗(yàn)室研究中，EIDD-2801還顯示出針對(duì)季節(jié)性流感、呼吸道合胞病毒、基孔肯雅病毒、埃博拉病毒、委內(nèi)瑞拉馬腦炎病毒和東部馬腦炎病毒的活性。
Molnupiravir ;EIDD-2801 is an orally bioavailable form of a highly potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19. EIDD-2801 has been shown to improve pulmonary function, decrease body weight loss and reduce the amount of virus in the lung. In addition to activity against coronaviruses, EIDD-2801, in laboratory studies, has demonstrated activity against seasonal and bird influenza, respiratory syncytial virus, chikungunya virus, Ebola virus, Venezuelan equine encephalitis virus, and Eastern equine encephalitis virus. EIDD-2801 is a prodrug of EIDD-1931.
關(guān)鍵字： EIDD-2801EIDD2801;MK4482);莫納匹拉韋;
公司簡(jiǎn)介
ANHUI HAIKANG PHARMACEUTICAL CO.,LTD. was established in 2009 in Anqing City, Anhui Province. It is located along the north bank of mid and lower reaches of the Yangtze River. Enjoying favorable? geographic superiorities and convenient transportation infrastructure: such as highway, high speed railway, airport, inland shipping container terminal and so on. By plane, it takes just 1 hour to Shanghai, 2 hours to Guangzhou or Beijing; by high speed train it takes 2 hours to reach Nanjing, 4 hours to Shanghai, 6.5 hours Beijing.Since founded the company has been committed to the production, sales
| 成立日期 |
2009-11-02
（16年）
|
注冊(cè)資本 |
貳仟貳佰伍拾萬(wàn)圓整
|
| 員工人數(shù) |
10-50人 |
年?duì)I業(yè)額 |
￥ 100萬(wàn)-300萬(wàn) |
| 主營(yíng)行業(yè) |
醫(yī)藥中間體,其他中間體,原料藥,呼吸系統(tǒng)用藥,其他抗感染類 |
經(jīng)營(yíng)模式 |
工廠,定制 |